0
Abstract: Poster Presentations |

P53-INDEPENDENT HEAT SENSITIZATION OF LUNG CANCER CELLS BY INHIBITORS TARGETING ONCOGENIC PATHWAYS FREE TO VIEW

Yoko Nagata, MD*; Takashi Tojo, PhD; Ken Ohnishi, PhD; Akihisa Takahashi, PhD; Takeo Ohnishi, PhD; Shigeki Taniguchi, PhD
Author and Funding Information

Nara Medical University School of Medicine, Kashihara, Japan


Chest


Chest. 2008;134(4_MeetingAbstracts):p157001. doi:10.1378/chest.134.4_MeetingAbstracts.p157001
Text Size: A A A
Published online

Abstract

PURPOSE: Activation of the mitogen activated extracellular signal protein kinase (MEK) and phosphatidylinositol-3 kinase (PI3K)/ Akt signaling pathways have been implicated in tumorigenesis, malignant cell proliferation and survival as well as in the resistant phenotype of a variety of human tumor cells to chemotherapy and irradiation. In hyperthermic cancer therapy, heat shock activates these anti-apoptotic/cellular proliferative signaling pathways, which is associated with heat-resistance. Additionally, accumulation of heat shock proteins (Hsps) also plays an anti-apoptotic role. To develop more effective strategies, it is significant to find effective heat sensitizers which can specifically inhibit the heat-induced activation of these prosurvival signalings and enhance heat-induced apoptosis.

METHODS: Using two human lung cancer cell lines, which were transfected with wild type p53 (H1299/wtp53) or mutated p53 gene (H1299/mp53), we investigated the effect of PD98059 (MEK inhibitor) and LY294002 (PI3K inhibitor), on heat sensitivity by colonogenic assay. In addition, the effects of these selective inhibitors on the several heat-induced key signaling factors, such as anti-apoptotic factors (survivin, Hsp27, Hsp70) and apoptotic factor (caspase-3), were analyzed with Western blot analysis. The efficacy of the induction of apoptosis were detected Hoechst33342 staining.

RESULTS: Both PD98059 and LY294002 sensitized two cell types of H1299/wtp53 and H1299/mp53 to heat. Furthermore, these two agents significantly suppressed heat-induced accumulation of survivin, Hsp27, Hsp70 and enhanced heat-induced activation of caspase-3 and apoptosis with an independent manner on p53 gene status.

CONCLUSION: It is suggested that combination of hyperthermia and MEK pathway inhibitor or PI3K/Akt pathway inhibitor provides effective hyperthermic strategies for the treatment of lung cancers regardless of p53 gene status.

CLINICAL IMPLICATIONS: Hyperthermic cancer therapy combined with MEK pathway inhibitors or PI3K/Akt pathway inhibitors has the potential to be a useful tool for refractory disease.

DISCLOSURE: Yoko Nagata, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, October 29, 2008

1:00 PM - 2:15 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543